BCHT(SH:688276) Zheng Quan Zhi Xing·2025-05-13 10:43Group 1 - The legal opinion letter confirms the legality of the convening and holding procedures of Changchun Baike Biotechnology Co., Ltd.'s 2024 annual shareholders' meeting [1][2][4] - The meeting was convened by the company's sixth board of directors and held on May 13, 2025, with a combination of on-site and online voting [3][4] - A total of 96 shareholders (or their proxies) attended the meeting, representing 290,916,681 shares, which is 70.3278% of the total voting shares [4][5] Group 2 - The voting results for the agenda items were as follows: - For the 2024 Board of Directors Work Report, 99.8660% voted in favor [5] - For the 2024 Supervisory Board Work Report, 99.8660% voted in favor [6] - For the 2024 Profit Distribution Plan, 99.9287% voted in favor [6] - For the 2024 Annual Report, 99.8340% voted in favor [7] - For the Director Compensation Plan, 99.3688% voted in favor, with related shareholders abstaining [8] - For the Supervisor Compensation Plan, 99.6008% voted in favor, with related shareholders abstaining [9] - For the appointment of the 2025 financial audit and internal control audit institutions, 99.8390% voted in favor [10] Group 3 - The legal opinion concludes that the convening, holding procedures, qualifications of the convenor and attendees, as well as the voting procedures and results of the meeting are all in compliance with relevant laws, regulations, and the company's articles of association [2][10]